Sexual Disorders: Dysfunction, Gender Identity, and Paraphilias

  • Nancy C. Raymond
  • Jon E. Grant

Sexual disorders in the Diagnostic and Statistical Manual, fourth edition, text revision (DSM-IV-TR) are divided into three major categories: 1) sexual dysfunctions, problems in sexual desire or disturbances in the psychophysiologic changes that are part of the sexual response cycle; 2) paraphilias, which involve recurrent intense sexual urges or fantasies, or behaviors that involve unusual objects, activities, or situations that are, by and large, not culturally sanctioned; and 3) gender identity disorders, which are characterized by dissatisfaction with one’s biological gender and often a desire to undergo gender reassignment. In this chapter, we review the diagnostic criteria, prevalence, etiology, assessment, and treatment of these disorders.

Key words

Compulsive sexual behavior Gender identity disorder Paraphilias Sexual dysfunction Sexual health 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th ed. Washington, DC: American Psychiatric Association; 2000.Google Scholar
  2. 2.
    World Health Organization. Challenges in Sexual and Reproductive Health: Technical Consultation on Sexual Health; January 2002:28–31.Google Scholar
  3. 3.
    World Health Organization. Education and Treatment in Human Sexuality: The Training of Health Professionals; 1975.Google Scholar
  4. 4.
    Coleman E. Promoting sexual health and responsible sexual behavior: an introduction. J Sex Res 2002;39(1):3–6.PubMedGoogle Scholar
  5. 5.
    Robinson BB, Bockting WO, Rosser BR, Miner M, Coleman E. The Sexual Health Model: application of a sexological approach to HIV prevention. Health Educ Res 2002;17(1): 43–57.PubMedCrossRefGoogle Scholar
  6. 6.
    Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000;2(3):189–195.PubMedCrossRefGoogle Scholar
  7. 7.
    Laumann EO. The social organization of sexuality: sexual practices in the United States. Chicago: University of Chicago Press; 1994.Google Scholar
  8. 8.
    Rosen RC, Leiblum SR. Treatment of sexual disorders in the 1990s: an integrated approach. J Consult Clin Psychol 1995;63(6):877–890.PubMedCrossRefGoogle Scholar
  9. 9.
    Drugs that cause sexual dysfunction: an update. Med Lett Drugs Ther 1992;34(876):73–78.Google Scholar
  10. 10.
    Anastasiadis AG, Davis AR, Salomon L, Burchardt M, Shabsigh R. Hormonal factors in female sexual dysfunction. Curr Opin Urol 2002;12(6):503–507.PubMedCrossRefGoogle Scholar
  11. 11.
    Mathur RS, Landgrebe SC, Moody LO, Semmens JP, Williamson HO. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas 1985;7(2):129–133.PubMedCrossRefGoogle Scholar
  12. 12.
    Robinson B, Feldman J, Striepe M, Raymond N, Mize S. Women’s sexual health: an interdisciplinary approach to treating low sexual desire. Minn Med 2003;86(7):34–41.PubMedGoogle Scholar
  13. 13.
    Guay A, Davis SR. Testosterone insufficiency in women: fact or fiction? World J Urol 2002;20(2):106–110.PubMedCrossRefGoogle Scholar
  14. 14.
    Mark A, Shifren J. Medical therapy for female sexual dysfunction. Primary Care Update for OB/GYNS 2003;10(1):40–43.CrossRefGoogle Scholar
  15. 15.
    Heiman JR. Sexual dysfunction: overview of prevalence, etiological factors, and treatments. J Sex Res 2002;39(1):73–78.PubMedGoogle Scholar
  16. 16.
    McCoy NL, Matyas JR. Oral contraceptives and sexuality in university women. Arch Sex Behav 1996;25(1):73–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Reagan P. Hormonal correlates and causes of sexual desire: a review. Can J Hum Sex 1999;8(1):1–16.Google Scholar
  18. 18.
    Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002;288(3):321–333.PubMedCrossRefGoogle Scholar
  19. 19.
    Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J Womens Health Gend Based Med 2000;9(Suppl 1):S25–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343(10):682–688.PubMedCrossRefGoogle Scholar
  21. 21.
    Davis SR. The role of androgens and the menopause in the female sexual response. Int J Impot Res 1998;10(Suppl 2):S82–83; discussion S98–101.PubMedGoogle Scholar
  22. 22.
    Heaton JP. Neural and pharmacological determinants of erection. Int J Impot Res 1998;10(Suppl 2):S34–39; discussion S49–51.Google Scholar
  23. 23.
    Goldstein I. Female sexual arousal disorder: new insights. Int J Impot Res 2000;12(Suppl 4):S152–157.Google Scholar
  24. 24.
    Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993;19(3):171–188.PubMedGoogle Scholar
  25. 25.
    Basson R. Clinical practice. Sexual desire and arousal disorders in women. N Engl J Med 2006;354(14):1497–1506.PubMedCrossRefGoogle Scholar
  26. 26.
    Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998;15(6):519–524.PubMedCrossRefGoogle Scholar
  27. 27.
    Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women’s Health Across the Nation (SWAN). Menopause 2005;12(4):385–398.PubMedCrossRefGoogle Scholar
  28. 28.
    van Lunsen RH, Laan E. Genital vascular responsiveness and sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies. Menopause 2004;11(6 Pt 2): 741–748.PubMedCrossRefGoogle Scholar
  29. 29.
    Stenberg A, Heimer G, Ulmsten U, Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas 1996;24(1–2):31–36.PubMedCrossRefGoogle Scholar
  30. 30.
    Panzer C, Wise S, Fantini G, et al. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med 2006;3(1):104–113.PubMedCrossRefGoogle Scholar
  31. 31.
    Santoro N, Torrens J, Crawford S, et al. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation. J Clin Endocrinol Metab 2005;90(8): 4836–4845.PubMedCrossRefGoogle Scholar
  32. 32.
    Arlt W. Androgen therapy in women. Eur J Endocrinol 2006;154(1):1–11.PubMedCrossRefGoogle Scholar
  33. 33.
    Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. Bjog 2003;110(11):1014–1024.PubMedGoogle Scholar
  34. 34.
    Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002;11(4):367–377.PubMedCrossRefGoogle Scholar
  35. 35.
    Beutel ME, Weidner W, Brahler E. Epidemiology of sexual dysfunction in the male population. Andrologia 2006;38(4):115–121.PubMedCrossRefGoogle Scholar
  36. 36.
    Wespes E, Amar E, Hatzichristou D, et al. EAU Guidelines on erectile dysfunction: an update. Eur Urol 2006;49(5): 806–815.PubMedCrossRefGoogle Scholar
  37. 37.
    Heiman JR, Grafton-Becker V. Orgasmic disorders in women. New York: Guilford Press; 1989.Google Scholar
  38. 38.
    Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990;19(4):389–408.PubMedCrossRefGoogle Scholar
  39. 39.
    LoPiccolo J, Stock WE. Treatment of sexual dysfunction. J Consult Clin Psychol 1986;54(2):158–167.PubMedCrossRefGoogle Scholar
  40. 40.
    Richardson D, Nalabanda A, Goldmeier D. Retarded ejaculation—a review. Int J STD AIDS 2006;17(3):143–150.PubMedCrossRefGoogle Scholar
  41. 41.
    Gitlin MJ, Suri R, Altshuler L, Zuckerbrow-Miller J, Fairbanks L. Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. J Sex Marital Ther 2002;28(2): 131–138.PubMedCrossRefGoogle Scholar
  42. 42.
    Segraves RT. Reversal by bethanechol of imipramine-induced ejaculatory dysfunction. Am J Psychiatry 1987;144(9): 1243–1244.PubMedGoogle Scholar
  43. 43.
    Balogh S, Hendricks SE, Kang J. Treatment of fluoxetine-induced anorgasmia with amantadine. J Clin Psychiatry 1992;53(6):212–213.PubMedGoogle Scholar
  44. 44.
    Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19(3):268–271.PubMedCrossRefGoogle Scholar
  45. 45.
    Shrivastava RK, Shrivastava S, Overweg N, Schmitt M. Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1995;15(1):83–84.PubMedCrossRefGoogle Scholar
  46. 46.
    Mulhall JP. Current and future pharmacotherapeutic strategies in treatment of premature ejaculation. Urology 2006;67(1): 9–16.PubMedCrossRefGoogle Scholar
  47. 47.
    Meana M, Binik YM. Painful coitus: a review of female dyspareunia. J Nerv Ment Dis 1994;182(5):264–272.PubMedCrossRefGoogle Scholar
  48. 48.
    Ponticas Y. Sexual aversion versus hypoactive sexual desire: a diagnostic challenge. Psychiatr Med 1992;10(2):273–281.PubMedGoogle Scholar
  49. 49.
    HBIGDA. The Standards of Care for Gender Identity Disorders. 6th version. 2001.Google Scholar
  50. 50.
    Feldman J, Bockting W. Transgender health. Minn Med 2003;86(7):25–32.PubMedGoogle Scholar
  51. 51.
    Carlstedt A, Innala S, Brimse A, Soderstrom Anckarsater H. Mental disorders and DSM-IV paedophilia in 185 subjects convicted of sexual child abuse. Nord J Psychiatry 2005;59(6): 534–537.PubMedCrossRefGoogle Scholar
  52. 52.
    Weinberg TS. Sadomasochism and the social sciences: a review of the sociological literature and social psychological literature. Binghamton, NY: Harrington Park Press; 2006.Google Scholar
  53. 53.
    Briere J, Runtz M. University males’ sexual interest in children: predicting potential indices of “pedophilia” in a nonforensic sample. Child Abuse Negl 1989;13(1):65–75.PubMedCrossRefGoogle Scholar
  54. 54.
    Templeman TL, Stinnett RD. Patterns of sexual arousal and history in a “normal” sample of young men. Arch Sex Behav 1991;20(2):137–150.PubMedCrossRefGoogle Scholar
  55. 55.
    Abel GG, Rouleau JL, Osborn CA. Sexual disorders. 2nd ed. Philadelphia: Saunders; 1994.Google Scholar
  56. 56.
    Grant JE. Clinical characteristics and psychiatric comorbidity in males with exhibitionism. J Clin Psychiatry 2005;66(11): 1367–1371.PubMedGoogle Scholar
  57. 57.
    Allen A, Hollander E. Sexual Compulsions. Washington, DC: American Psychiatric Publishing, Inc.; 2005.Google Scholar
  58. 58.
    Chow EW, Choy AL. Clinical characteristics and treatment response to SSRI in a female pedophile. Arch Sex Behav 2002;31(2):211–215.PubMedCrossRefGoogle Scholar
  59. 59.
    Grob CS. Female exhibitionism. J Nerv Ment Dis 1985;173(4):253–256.PubMedGoogle Scholar
  60. 60.
    Kafka MP, Hennen J. A DSM-IV Axis I comorbidity study of males (n=120) with paraphilias and paraphilia-related disorders. Sexual Abuse 2002;14(4):349–366.PubMedCrossRefGoogle Scholar
  61. 61.
    Raymond NC, Coleman E, Ohlerking F, Christenson GA, Miner M. Psychiatric comorbidity in pedophilic sex offenders. Am J Psychiatry 1999;156(5):786–788.PubMedGoogle Scholar
  62. 62.
    Abel GG, Osborn C. The paraphilias. The extent and nature of sexually deviant and criminal behavior. Psychiatr Clin North Am 1992;15(3):675–687.PubMedGoogle Scholar
  63. 63.
    Firestone P, Kingston DA, Wexler A, Bradford JM. Long-term follow-up of exhibitionists: psychological, phallometric, and offense characteristics. J Am Acad Psychiatry Law 2006;34(3):349–359.PubMedGoogle Scholar
  64. 64.
    Heil P, Ahlmeyer S, Simons D. Crossover sexual offenses. Sex Abuse 2003;15(4):221–236.PubMedGoogle Scholar
  65. 65.
    Bradford JM. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour. Can J Psychiatry 2001;46(1):26–34.PubMedGoogle Scholar
  66. 66.
    Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57(11):1012–1030.PubMedCrossRefGoogle Scholar
  67. 67.
    Miller BL, Cummings JL, McIntyre H, Ebers G, Grode M. Hypersexuality or altered sexual preference following brain injury. J Neurol Neurosurg Psychiatry 1986;49(8): 867–873.PubMedCrossRefGoogle Scholar
  68. 68.
    Comings DE, Comings BG. Tourette syndrome: clinical and psychological aspects of 250 cases. Am J Hum Genet 1985;37(3):435–450.PubMedGoogle Scholar
  69. 69.
    Burns JM, Swerdlow RH. Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign. Arch Neurol 2003;60(3):437–440.PubMedCrossRefGoogle Scholar
  70. 70.
    Tost H, Vollmert C, Brassen S, Schmitt A, Dressing H, Braus DF. Pedophilia: neuropsychological evidence encouraging a brain network perspective. Med Hypotheses 2004;63(3): 528–531.PubMedCrossRefGoogle Scholar
  71. 71.
    Kafka MP. A monoamine hypothesis for the pathophysiology of paraphilic disorders. Arch Sex Behav 1997;26(4): 343–358.PubMedCrossRefGoogle Scholar
  72. 72.
    Kafka MP. The monoamine hypothesis for the pathophysiology of paraphilic disorders: an update. Ann N Y Acad Sci 2003;989:86–94; discussion 144–153.PubMedGoogle Scholar
  73. 73.
    Maletzky BM. The paraphilias: research and treatment. 2nd ed. New York: Oxford University Press; 2002.Google Scholar
  74. 74.
    Maletzky BM. Evolution, psychopathology, and sexual offending: aping our ancestors. Aggression and Violent Behavior: A Review 1996;1(4):369–373.CrossRefGoogle Scholar
  75. 75.
    McGuire RJ, Carlisle JM, Young BG. Sexual deviations as conditioned behaviour: a hypothesis. Behav Res Ther 1965;3: 185–190.PubMedCrossRefGoogle Scholar
  76. 76.
    Smallbone SW, Dadds MR. Attachment and coercive sexual behavior. Sex Abuse 2000;12(1):3–15.PubMedGoogle Scholar
  77. 77.
    Dwyer SM. Treatment outcome study: 17 years after sexual offender treatment. Sex Abuse 1997;9(2):149–160.CrossRefGoogle Scholar
  78. 78.
    Grossman LS, Martis B, Fichtner CG. Are sex offenders treatable? A research overview. Psychiatr Serv 1999;50(3): 349–361.PubMedGoogle Scholar
  79. 79.
    Hanson RK, Gordon A, Harris AJ, et al. First report of the collaborative outcome data project on the effectiveness of psychological treatment for sex offenders. Sex Abuse 2002;14(2):169–194; discussion 95–97.PubMedGoogle Scholar
  80. 80.
    Gijs L, Gooren L. Hormonal and psychopharmacological interventions in the treatment of paraphilias: an update. J Sex Res 1996;33(4):273–290.Google Scholar
  81. 81.
    Briken P, Hill A, Berner W. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review. J Clin Psychiatry 2003;64(8):890–897.PubMedGoogle Scholar
  82. 82.
    Dickey R. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 1992;37(8):567–569.PubMedGoogle Scholar
  83. 83.
    Rosler A, Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 1998;338(7):416–422.PubMedCrossRefGoogle Scholar
  84. 84.
    Abouesh A, Clayton A. Compulsive voyeurism and exhibitionism: a clinical response to paroxetine. Arch Sex Behav 1999;28(1):23–30.PubMedCrossRefGoogle Scholar
  85. 85.
    Kafka MP. Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 1994;6(3):189–195.PubMedCrossRefGoogle Scholar
  86. 86.
    Perilstein RD, Lipper S, Friedman LJ. Three cases of paraphilias responsive to fluoxetine treatment. J Clin Psychiatry 1991;52(4):169–170.PubMedGoogle Scholar
  87. 87.
    Black DW, Kehrberg LL, Flumerfelt DL, Schlosser SS. Characteristics of 36 subjects reporting compulsive sexual behavior. Am J Psychiatry 1997;154(2):243–249.PubMedGoogle Scholar
  88. 88.
    Coleman E. Is your patient suffering from compulsive sexual behavior? Psychiatric Annals 1992;22(6):320–325.Google Scholar
  89. 89.
    Kafka MP, Prentky RA. Compulsive sexual behavior characteristics. Am J Psychiatry 1997;154(11):1632.PubMedGoogle Scholar
  90. 90.
    Kafka MP. The paraphilia-related disorders: A proposal for a unified classification of nonparaphilic hypersexuality disorders. Sexual Addiction & Compulsivity 2001;8:227–239.CrossRefGoogle Scholar
  91. 91.
    Kafka MP. Hypersexual desire in males: an operational definition and clinical implications for males with paraphilias and paraphilia-related disorders. Arch Sex Behav 1997;26(5): 505–526.PubMedCrossRefGoogle Scholar
  92. 92.
    Atwood JD, Gagnon J. Masturbatory behavior in college youth. J Sex Educ Ther 1987;13:35–42.Google Scholar
  93. 93.
    Kinsey AC, Pomeroy WB, Martin CE. Sexual behavior in the human male. Philadelphia: W.B. Saunders Co.; 1948.Google Scholar
  94. 94.
    Kafka MP, Hennen J. The paraphilia-related disorders: an empirical investigation of nonparaphilic hypersexuality disorders in outpatient males. J Sex Marital Ther 1999;25(4): 305–319.PubMedCrossRefGoogle Scholar
  95. 95.
    Raymond NC, Coleman E, Miner MH. Psychiatric comorbidity and compulsive/impulsive traits in compulsive sexual behavior. Compr Psychiatry 2003;44(5):370–380.PubMedCrossRefGoogle Scholar
  96. 96.
    Grant JE, Levine L, Kim D, Potenza MN. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005;162(11):2184–2188.PubMedCrossRefGoogle Scholar
  97. 97.
    Coleman E, Raymond N, McBean A. Assessment and treatment of compulsive sexual behavior. Minn Med 2003;86(7):42–47.PubMedGoogle Scholar
  98. 98.
    Carnes P. Out of the Shadows: Understanding Sexual Addiction. Minneapolis, MN; 1983.Google Scholar
  99. 99.
    Goodman A. Diagnosis and treatment of sexual addiction. J Sex Marital Ther 1993;19(3):225–251.PubMedGoogle Scholar
  100. 100.
    Kafka MP. Paraphilia-related disorders—common, neglected, and misunderstood. Harv Rev Psychiatry 1994;2(1):39–40; discussion 1–2.PubMedCrossRefGoogle Scholar
  101. 101.
    Schaffer SD, Zimmerman ML. The sexual addict: a challenge for the primary care provider. Nurse Pract 1990;15(6):25–26, 8, 33.PubMedCrossRefGoogle Scholar
  102. 102.
    Barth RJ, Kinder BN. The mislabeling of sexual impulsivity. J Sex Marital Ther 1987;13(1):15–23.PubMedGoogle Scholar
  103. 103.
    Money J. Lovemaps: clinical concepts of sexual/erotic health and pathology, paraphilia, and gender transposition in childhood, adolescence, and maturity. New York: Irvington; 1986.Google Scholar
  104. 104.
    Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998;59:159–164.PubMedGoogle Scholar
  105. 105.
    Raymond NC, Grant JE, Kim SW, Coleman E. Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies. Int Clin Psychopharmacol 2002;17(4):201–205.PubMedCrossRefGoogle Scholar
  106. 106.
    Elliott ML, Biever LS. Head injury and sexual dysfunction. Brain Inj 1996;10(10):703–717.PubMedCrossRefGoogle Scholar
  107. 107.
    Huws R, Shubsachs AP, Taylor PJ. Hypersexuality, fetishism and multiple sclerosis. Br J Psychiatry 1991;158:280–281.PubMedGoogle Scholar
  108. 108.
    Mendez MF, Chow T, Ringman J, Twitchell G, Hinkin CH. Pedophilia and temporal lobe disturbances. J Neuropsychiatry Clin Neurosci 2000;12(1):71–76.PubMedGoogle Scholar
  109. 109.
    Monga TN, Monga M, Raina MS, Hardjasudarma M. Hypersexuality in stroke. Arch Phys Med Rehabil 1986;67(6): 415–417.PubMedGoogle Scholar
  110. 110.
    Wainberg ML, Muench F, Morgenstern J, et al. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry 2006;67(12):1968–1973.PubMedCrossRefGoogle Scholar
  111. 111.
    Bourgeois JA, Klein M. Risperidone and fluoxetine in the treatment of pedophilia with comorbid dysthymia. J Clin Psychopharmacol 1996;16(3):257–258.PubMedCrossRefGoogle Scholar
  112. 112.
    Coleman E, Cesnik J, Moore A-M, Dwyer SM. An exploratory study of the role of psychotropic medications in the treatment of sex offenders. Journal of Offender Rehabilitation 1992;18(3/4):75–88.CrossRefGoogle Scholar
  113. 113.
    Emmanuel NP, Lydiard RB, Ballenger JC. Fluoxetine treatment of voyeurism. Am J Psychiatry 1991;148(7):950.PubMedGoogle Scholar
  114. 114.
    Fedoroff JP. Serotenergic drugs treatment of deviant sexual interests. Annals Sex Res 1993;6:105–121.CrossRefGoogle Scholar
  115. 115.
    Kafka MP. Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 1991;52(2):60–65.PubMedGoogle Scholar
  116. 116.
    Kafka MP, Coleman E. Serotonin and paraphilias: the convergence of mood, impulse and compulsive disorders. J Clin Psychopharmacol 1991;11(3):223–224.PubMedCrossRefGoogle Scholar
  117. 117.
    Kafka MP, Prentky R. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 1992;53(10):351–358.PubMedGoogle Scholar
  118. 118.
    Pearson HJ. Paraphilias, impulse control, and serotonin. J Clin Psychopharmacol 1990;10(3):233.PubMedCrossRefGoogle Scholar
  119. 119.
    Stein DJ, Hollander E, Anthony DT, et al. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. J Clin Psychiatry 1992;53(8):267–271.PubMedGoogle Scholar
  120. 120.
    Kruesi MJ, Fine S, Valladares L, Phillips RA Jr, Rapoport JL. Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine. Arch Sex Behav 1992;21(6): 587–593.PubMedCrossRefGoogle Scholar
  121. 121.
    Fedoroff JP. Buspirone hydrochloride in the treatment of an atypical paraphilia. Arch Sex Behav 1992;21(4):401–406.PubMedCrossRefGoogle Scholar
  122. 122.
    Fedoroff JP. Buspirone hydrochloride in the treatment of transvestic fetishism. J Clin Psychiatry 1988;49(10): 408–409.PubMedGoogle Scholar
  123. 123.
    Coleman E, Gratzer T, Nesvacil L, Raymond NC. Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study. J Clin Psychiatry 2000;61(4):282–284.PubMedGoogle Scholar
  124. 124.
    Cesnik JA, Coleman E. Use of lithium carbonate in the treatment of autoerotic asphyxia. Am J Psychother 1989;43(2): 277–286.PubMedGoogle Scholar
  125. 125.
    Ward NG. Successful lithium treatment of transvestism associated with manic-depression. J Nerv Ment Dis 1975;161(3): 204–206.PubMedCrossRefGoogle Scholar
  126. 126.
    Grant JE, Kim SW. Gender differences in pathological gamblers seeking medication treatment. Compr Psychiatry 2002;43(1):56–62.PubMedCrossRefGoogle Scholar
  127. 127.
    Kim SW, Grant JE, Yoon G, Williams KA, Remmel RP. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol 2006;29(2): 77–79.PubMedCrossRefGoogle Scholar
  128. 128.
    Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. International Index of Erectile Function (IIEF): a multidimensional scale for measurement of erectile dysfunction. Urology 1997;49:822–830.PubMedCrossRefGoogle Scholar
  129. 129.
    Sivalingam S, Hashim H, Schwaibold H. An overview of the diagnosis and treatment of erectile dysfunction. Drugs 2006;60(18):2339–2355.CrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Nancy C. Raymond
  • Jon E. Grant

There are no affiliations available

Personalised recommendations